Marina Widmann1,2, Bernice Apondi3, Abednego Musau3, Abdulkadir Hussein Warsame4, Maimuna Isse4, Victoria Mutiso3, Clemens Veltrup5, David Ndetei3,6, Michael Odenwald7,8. 1. University of Konstanz, Box 23, 78457, Konstanz, Germany. 2. vivo international e.V., PO Box 5108, 78430, Konstanz, Germany. 3. Africa Mental Health Foundation, Mawensi Gardens, Upperhill Nairobi, Kenya. 4. Tawakal Medical Clinic, 5th street, Eastleigh, Nairobi, Kenya. 5. Fachklinik Freudenholm-Ruhleben, Postfach 5, 24301, Plön, Germany. 6. University of Nairobi, Nairobi, Kenya. 7. University of Konstanz, Box 23, 78457, Konstanz, Germany. Michael.odenwald@uni-konstanz.de. 8. vivo international e.V., PO Box 5108, 78430, Konstanz, Germany. Michael.odenwald@uni-konstanz.de.
Abstract
BACKGROUND AND AIMS: Migration and khat use were found to correlate with high rates of psychopathology. In this paper we aimed for assessing baseline multimorbidity and its interactions with a Brief Intervention. METHODS: In the RCT, 330 male Somali khat users were assigned to treatment conditions (khat use is a predominantly male habit). The ASSIST-linked BI for khat users was administered. Using the TLFB Calendar, the PHQ-9, a Somali short version of the PDS and parts from the CIDI, khat use and comorbidity was assessed. With a regression analysis we tested for the influence of comorbidity and with mixed effect models group differences over time in sleep duration, khat use-time and everyday functioning. RESULTS: We found high rates of baseline multimorbidity: 51% (N = 168) for depression, 22% (N = 74) for PTSD and 23% (N = 73) for khat-psychotic symptoms. Depression and khat-psychotic symptoms, but not PTSD symptoms decreased without group differences. Khat use-time decreased and functional time increased with significant time × group interactions (p ≤ 0.046). Depression and PTSD did not influence therapy success but in participants without comorbid psychopathology, more khat use reduction after the intervention was found (p = 0.024). CONCLUSION: Somali khat users in Kenya are highly burdened by multimorbidity of depression, PTSD and khat-psychotic symptoms. The main effects for time and differences in healthy vs. mentally ill khat users indicate potential of unspecific support and the specific need for mental health care in combination with substance abuse treatment. The increase of everyday functioning promises more options for alternative activities, preventing excessive use and addiction.
RCT Entities:
BACKGROUND AND AIMS: Migration and khat use were found to correlate with high rates of psychopathology. In this paper we aimed for assessing baseline multimorbidity and its interactions with a Brief Intervention. METHODS: In the RCT, 330 male Somali khat users were assigned to treatment conditions (khat use is a predominantly male habit). The ASSIST-linked BI for khat users was administered. Using the TLFB Calendar, the PHQ-9, a Somali short version of the PDS and parts from the CIDI, khat use and comorbidity was assessed. With a regression analysis we tested for the influence of comorbidity and with mixed effect models group differences over time in sleep duration, khat use-time and everyday functioning. RESULTS: We found high rates of baseline multimorbidity: 51% (N = 168) for depression, 22% (N = 74) for PTSD and 23% (N = 73) for khat-psychotic symptoms. Depression and khat-psychotic symptoms, but not PTSD symptoms decreased without group differences. Khat use-time decreased and functional time increased with significant time × group interactions (p ≤ 0.046). Depression and PTSD did not influence therapy success but in participants without comorbid psychopathology, more khat use reduction after the intervention was found (p = 0.024). CONCLUSION: Somali khat users in Kenya are highly burdened by multimorbidity of depression, PTSD and khat-psychotic symptoms. The main effects for time and differences in healthy vs. mentally ill khat users indicate potential of unspecific support and the specific need for mental health care in combination with substance abuse treatment. The increase of everyday functioning promises more options for alternative activities, preventing excessive use and addiction.
Authors: Stefan W Toennes; Sebastian Harder; Markus Schramm; Constanze Niess; Gerold F Kauert Journal: Br J Clin Pharmacol Date: 2003-07 Impact factor: 4.335
Authors: Kamaldeep Bhui; Tom Craig; Salaad Mohamud; Nasir Warfa; Stephen A Stansfeld; Graham Thornicroft; Sarah Curtis; Paul McCrone Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2006-03-06 Impact factor: 4.328
Authors: K Adorjan; S Mulugeta; M Odenwald; D M Ndetei; A H Osman; M Hautzinger; S Wolf; M Othman; J I Kizilhan; O Pogarell; T G Schulze Journal: Nervenarzt Date: 2017-09 Impact factor: 1.214
Authors: M Claire Greene; Susan Rees; Samuel Likindikoki; Ann G Bonz; Amy Joscelyne; Debra Kaysen; Reginald D V Nixon; Tasiana Njau; Marian T A Tankink; Agnes Tiwari; Peter Ventevogel; Jessie K K Mbwambo; Wietse A Tol Journal: Confl Health Date: 2019-08-17 Impact factor: 2.723